There were 18 votes (excluding one vote for “No answer.”)
Q: What effect will ABBV’s decision to set the US list price of Viekira Pak at $83.3K (rather than a lower price) have on cumulative sales of Viekira Pak in the US and EU combined over the life of the product?
a) It will materially INCREASE cumulative sales: 50% b) It will materially DECREASE cumulative sales: 39% c) It will have NO MATERIAL EFFECT on cumulative sales: 11%
Thanks to all of the participants for participating.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.